These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17701274)

  • 1. Perspectives of biomolecular NMR in drug discovery: the blessing and curse of versatility.
    Jahnke W
    J Biomol NMR; 2007 Oct; 39(2):87-90. PubMed ID: 17701274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting biomolecular NMR spectroscopy for promoting small-molecule drug discovery.
    Hanzawa H; Shimada T; Takahashi M; Takahashi H
    J Biomol NMR; 2020 Nov; 74(10-11):501-508. PubMed ID: 32306215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on NMR in drug discovery: a technique comes of age.
    Pellecchia M; Bertini I; Cowburn D; Dalvit C; Giralt E; Jahnke W; James TL; Homans SW; Kessler H; Luchinat C; Meyer B; Oschkinat H; Peng J; Schwalbe H; Siegal G
    Nat Rev Drug Discov; 2008 Sep; 7(9):738-45. PubMed ID: 19172689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of NMR screening in drug discovery.
    Fejzo J; Lepre C; Xie X
    Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Segmental Isotopic Labeling of Proteins for NMR Study Using Intein Technology.
    Liu D; Cowburn D
    Methods Mol Biol; 2017; 1495():131-145. PubMed ID: 27714614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR in the acceleration of drug discovery.
    Sem DS; Pellecchia M
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):479-92. PubMed ID: 11727313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of NMR and high-throughput screening.
    Hajduk PJ; Burns DJ
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):613-21. PubMed ID: 12470258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-site NMR screening and linker design.
    Jahnke W; Flörsheimer A; Blommers MJ; Paris CG; Heim J; Nalin CM; Perez LB
    Curr Top Med Chem; 2003; 3(1):69-80. PubMed ID: 12570778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automation of biomolecular NMR screening.
    Ross A; Senn H
    Curr Top Med Chem; 2003; 3(1):55-67. PubMed ID: 12570777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomolecular NMR: a chaperone to drug discovery.
    Betz M; Saxena K; Schwalbe H
    Curr Opin Chem Biol; 2006 Jun; 10(3):219-25. PubMed ID: 16679046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-based approaches for lead discovery.
    Wyss DF; McCoy MA; Senior MM
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):630-47. PubMed ID: 12197321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state NMR of flavins and flavoproteins.
    Miller AF
    Methods Mol Biol; 2014; 1146():307-40. PubMed ID: 24764096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR in structure-based drug design.
    Carneiro MG; Ab E; Theisgen S; Siegal G
    Essays Biochem; 2017 Nov; 61(5):485-493. PubMed ID: 29118095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of NMR in lead optimization: fragment-based approaches.
    Huth JR; Sun C
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):631-43. PubMed ID: 12470260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions in NMR Tubes as Key Weapon in Rational Drug Design.
    Ntountaniotis D
    Methods Mol Biol; 2018; 1824():417-430. PubMed ID: 30039422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of NMR to structure-based drug design in structural genomics.
    Powers R
    J Struct Funct Genomics; 2002; 2(2):113-23. PubMed ID: 12836668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvesicles as mediators of intercellular communication in cancer.
    Antonyak MA; Cerione RA
    Methods Mol Biol; 2014; 1165():147-73. PubMed ID: 24839024
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.